—From yesterday presentation according to Dr NP
Post# of 148192
They see great results on 525 , after 26 weeks after the first 10 weeks , 95% efficacy for 525 , and they said yesterday that FDA advised them not to stop this dose ..
We not sure why this is happening. But probably because Leronlimab is also activating immune responses in our body .
—But for cancer Dr RP said they will try to use 700 mg , if patients will tolerate it .
As for centers I heard that they don’t have a problems with enrollment , this was not a reason for delays . Legality and preparation was .
So now after testing will be finish things should go smoothly .
And they still have on the slide 1H for licensing of prostate cancer , so it make takes some weeks still , but look close.